AstraZeneca is strengthening its oncology portfolio with another major strategic investment, signing an exclusive global licensing agreement worth up to $1.5 billion for Zegfrovy, an innovative targeted therapy for a specific type of lung cancer developed by China’s Dizal Pharmaceutical. The London-based biopharmaceutical company announced that it will acquire worldwide
Intel has announced a major €5 billion investment in its Leixlip campus in Ireland, reinforcing its commitment to expanding advanced
Sign up for exclusive industry news, blogs, and success stories.
ClinicMind is a comprehensive, vertically integrated healthcare platform designed to help practice owners grow, streamline operations, and enhance patient care. Recognized as G2’s Undisputed Leader for 12 consecutive quarters (2022–2025), it supports the full care journey—from patient acquisition and EHR to billing and revenue cycle management. With AI-powered tools like AI Scribe and advanced RCM solutions, ClinicMind improves workflows, boosts engagement, and maximizes revenue while ensuring better outcomes and seamless user experience.
Be the Visionary Leader Everyone’s Talking About
Request Media Kit to get Following:
Are you looking to reach your target audience?
Fill the details to get
